Related Experiment Video
Updated: Jan 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Bacterial Infection Spectrum and Antimicrobial Resistance in 2850 Cases of Community-Acquired Pneumonia in Children]
Meijiao Zhong1, Jiang Xie1, Hui Wang1
1·() ( 610072) Department of Pediatrics, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Insights
This study analyzed bacterial pathogens in pediatric community-acquired pneumonia (CAP), finding that age influences the risk of infection by specific bacteria like Staphylococcus aureus and Streptococcus pneumoniae. High drug resistance rates were observed for common pathogens, emphasizing the need for targeted clinical treatment strategies.
Area of Science:
- Pediatric infectious diseases
- Microbiology
- Clinical epidemiology
Objective:
To analyze the distribution characteristics and drug resistance of bacterial pathogens in children with community-acquired pneumonia (CAP) in a single center, and to provide evidence for clinical diagnosis and treatment.
Methods:
A total of 2850 children with CAP admitted to the Department of Pediatrics of a tertiary hospital in Sichuan between January 2022 and December 2024 were enrolled. Clinical data, sputum culture and bacterial drug sensitivity results, and respiratory pathogen nucleic acid testing results were collected. A retrospective analysis was conducted on the clinical data, etiological testing results, and drug sensitivity data.
Results:
Among the 2850 CAP children, the overall pathogen positivity rate was 73.4% (2093/2850), with viral, bacterial, and Mycoplasma pneumoniae/Chlamydia pneumoniae infections accounting for 33.6% (958/2850), 32.6% (929/2850), and 24.7% (703/2850), respectively. The predominant bacterial pathogens identified were Haemophilus influenzae (38.8%), Streptococcus pneumoniae (29.7%), Moraxella catarrhalis (21.4%), and Staphylococcus aureus (10.1%). Multivariable logistic regression analysis (Bonferroni-corrected) revealed that age was an independent risk factor for bacterial infection, although the risk profile varied by bacterial species. The risk of Staphylococcus aureus infection was highest during infancy (infancy adjusted odds ratio [aOR] = 1) and was significantly lower among the school-age children (aOR = 0.09, 95% CI: 0.02-0.52). The risk of Streptococcus pneumoniae infection peaked in the preschool children (aOR = 2.66, 95% CI: 1.75-4.05), followed by school-age children (aOR = 2.60, 95% CI: 1.48-4.57) and toddlers (aOR = 1.90, 95% CI: 1.26-2.87). The risk of Moraxella catarrhalis infection significantly decreased in school-age children (aOR = 0.24, 95% CI: 0.08-0.69). Antimicrobial susceptibility testing demonstrated that the resistance rates of Haemophilus influenzae and Moraxella catarrhalis to ampicillin were 75.45% and 41.53%, respectively. The resistance rate of Streptococcus pneumoniae to erythromycin was 93.75%, while that of Staphylococcus aureus to penicillin was 83.33%.
Conclusion:
In this pediatric CAP cohort, the main bacterial pathogens are Haemophilus influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, and Staphylococcus aureus. The distribution of bacterial pathogens exhibits distinct age-specific characteristics.
More Related Videos
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Gene Regulation in Microbial Communities: Quorum Sensing
Acute Pyelonephritis II: Diagnostic Studies and Management